Synthetic peptides modulate epithelial junctions

K-REx Repository

Show simple item record Yi, Sheng 2009-12-18T21:41:20Z 2009-12-18T21:41:20Z 2009-12-18T21:41:20Z
dc.description.abstract Peptides based on the second transmembrane segment of the glycine receptor (M2GlyR) were made to provide a potential therapeutic treatment for cystic fibrosis (CF) and a latent absorption enhancer for drug delivery. For similarity of presentation, unique synthetic peptide sequences have been given alpha-numeric designations. Results are presented from studies focusing on four peptides. In the first study, the contributions of synthetic peptides p1171, p1172 and p1173 to net transepithelial ion transport were measured as a first step toward the goal of testing whether pore length or electrostatics of pore lining residues will affect anion transport. Peptide p1130 exhibits many attributes that make it an ideal synthetic peptide for CF treatment, but has low permselectivity for anions. Therefore, it is used as a platform for modification. Peptide p1171 is doubly substituted with diaminopropionic acid at positions T13 and T17. Peptide p1172 and p1173 are separately one and two helical turn(s) inserted into the p1130 backbone. Apical exposure of MDCK monolayers to these peptides caused a rapid increase in short circuit current (Isc), an indicator of net ion transport. The increase in Isc caused by p1172 or p1173 was accompanied by increase in transepithelial electrical conductance (gte). The electrophysiological results suggested that these modified peptides can assemble in the apical membrane of epithelial cells to form functional ion-conducting pores. Peptide NC-1059, which provides for ion transport across epithelial cells derived from many sources, was studied further to assess cellular changes that account for increased gte. NC-1059 increased Isc, gte and enhanced permeation of dextrans in a concentration dependent manner. Results from previous and current studies show that NC-1059 modulated the epithelial paracellular pathway by altering the distribution and abundance of junctional proteins. Immunoblotting and immunolabeling with confocal microscopy showed that NC-1059 induces reorganization of actin and causes a reduction in F-actin abundance in epithelial cells. The distributions were changed and cellular abundances were reduced of tight junction proteins occludin and ZO-1 and adherens junction proteins E-cadherin and β-catenin by NC-1059. These effects were largely reversed in 24 hr and fully recovered in 48 hr. Therefore, NC-1059 has the therapeutic potential to increase the efficiency of drug delivery across barrier membranes. en_US
dc.description.sponsorship National Institutes of Health (GM 074096 to JMT); COBRE Epithelial Function in Health and Disease (P20 RRO17686). en_US
dc.language.iso en_US en_US
dc.publisher Kansas State University en
dc.subject Synthetic peptides en_US
dc.subject Occludin en_US
dc.subject ZO-1 en_US
dc.subject Actin en_US
dc.subject Paracellular permeability en_US
dc.subject Transepithelial conductance en_US
dc.title Synthetic peptides modulate epithelial junctions en_US
dc.type Thesis en_US Master of Science en_US
dc.description.level Masters en_US
dc.description.department Department of Biochemistry en_US
dc.description.advisor Bruce D. Schultz en_US
dc.description.advisor John M. Tomich en_US
dc.subject.umi Biology, Cell (0379) en_US
dc.subject.umi Chemistry, Biochemistry (0487) en_US 2009 en_US December en_US

Files in this item

This item appears in the following Collection(s)

Show simple item record

Search K-REx

Advanced Search


My Account

Center for the

Advancement of Digital


118 Hale Library

Manhattan KS 66506

(785) 532-7444